Leadership & Pay ·
PROCEPT BioRobotics expands board to ten members, appoints Dr. Michael Mack as Class II director
PRCTPROCEPT BioRobotics Corp
On October 2, 2026, the Board of Directors of PROCEPT BioRobotics Corporation approved an increase in board size from nine to ten members. The company appointed Dr. Michael Mack as a new Class II director to fill the vacancy, effective immediately. His term expires at the 2029 annual meeting. Dr. Mack is an independent cardiac surgeon with extensive leadership experience in thoracic surgery and medical research institutions. He will receive compensation consistent with other non-employee directors. PROCEPT BioRobotics Corporation operates in the medical device industry, developing robotic-assisted surgical systems for urology and gynecology.